upadacitinib hemihydrate

Spain

Drugs containing this active substance

  • RINVOQ 15 MG PROLONGED-RELEASE TABLETS

    It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, giant cell arteritis, atopic dermatitis, ulcerative colitis, and Crohn's disease.

    Form: tablets, prolonged-release

    Active substance Dosage
    upadacitinib hemihydrate 15,4 mg

    ATC: L04A L04AF L04AF03

    Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

  • It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, giant cell arteritis, atopic dermatitis, ulcerative colitis, and Crohn's disease.

    Form: tablets, prolonged-release

    Active substance Dosage
    upadacitinib hemihydrate 30,7 mg

    ATC: L04A L04AF L04AF03

    Manufacturer: Abbvie Deutschland Gmbh & Co. Kg

  • It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, giant cell arteritis, atopic dermatitis, ulcerative colitis, and Crohn's disease.

    Form: tablets, prolonged-release

    Active substance Dosage
    upadacitinib hemihydrate 46,1 mg

    ATC: L04A L04AF L04AF03

    Manufacturer: Abbvie Deutschland Gmbh & Co. Kg